Hu R, Lu C, Lu S, et al. Value of CXCL13 in diagnosing asymptomatic neurosyphilis in HIV-infected patients. Int J STD AIDS Epub ahead of print 2015 March 12. DOI: 0956462415577229.
2.
ZhouPGuXLuH. Re-evaluation of serological criteria for early syphilis treatment efficacy: progression to neurosyphilis despite therapy. Sex Transm Infect2012; 88: 342–345.
3.
GiacaniLDenisenkoOTompaM. Identification of the Treponema pallidum subsp. pallidum TP0092 (RpoE) regulon and its implications for pathogen persistence in the host and syphilis pathogenesis. J Bacteriol2013; 195: 896–907.
4.
BerndtsonK. Review of evidence for immune evasion and persistent infection in Lyme disease. Int J Gen Med2013; 6: 291–306.
5.
BarbourA. Remains of infection. J Clin Invest2012; 122: 2344–2346.
6.
PastuszczakMJakielaBWielowieyska-SzybinskaD. Elevated cerebrospinal fluid interleukin-17A and interferon γ levels in early asymptomatic neurosyphilis. Sex Transm Dis2013; 40: 808–812.
7.
LiKWangCLuH. Regulatory T cells in peripheral blood and cerebrospinal fluid of syphilis patients with and without neurological involvement. PLoS Negl Trop Dis2013; 7: e2528–e2528.
8.
MarraCMTantaloLCSahiSK. CXCL13 as a cerebrospinal fluid marker for neurosyphilis in HIV-infected patients with syphilis. Sex Transm Dis2010; 37: 283–287.
